CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

“Unparalleled opportunity”: Sandoz embarks on ambitious biosimilar growth strategy

Positive
AI Analysis

Summary

Sandoz announced an ambitious biosimilar growth strategy targeting more than 100 biosimilars in its portfolio by 2040, compared to its current portfolio of 13 biosimilars.

Importance:3/10
Sentiment:
0.60
biosimilarsportfolio expansiongrowth strategy
Related Companies

Read the original article

Published by Pharmaceutical Technology on September 9, 2026 10:19 AM

Read Original